Purdy’s Wharf Tower II
Suite 2001 1969 Upper Water Street
Halifax, NS B3J 3R7
Canada
902 442 0653
https://www.sonanano.com
Secteur(s): Healthcare
Secteur d’activité: Diagnostics & Research
Employés à temps plein:
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. David Andrew Regan | Chief Executive Officer | 189,76k | S.O. | 1969 |
Mr. Robert William George Randall CPA | CFO & Corporate Secretary | 46,06k | S.O. | 1963 |
Dr. Len Pagliaro Ph.D. | CSO & Director | 159,58k | S.O. | S.O. |
Dr. Kulbir Singh Ph.D. | Co-Founder & Head of R&D | S.O. | S.O. | S.O. |
Dr. Mike McAlduff | Director of R&D & Production and Founder | S.O. | S.O. | S.O. |
Dr. Gerrard Marangoni | Co-Founder & Member of Scientific Advisory Board | S.O. | S.O. | S.O. |
Mr. Darren Rowles | Head of Diagnostics | 137,94k | S.O. | 1979 |
Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia therapy for cancer treatment; and nanomedical therapy for the treatment of colorectal cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; bovine TB tests; and concussion screening tests. Sona Nanotech Inc. was founded in 2013 and is based in Halifax, Canada.
L’ISS Governance QualityScore de Sona Nanotech Inc. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..